The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...

which originally developed the drug, and Pfizer (NYSE:PFE). Kimbrow, 73, said he took Zantac from 1995 to 2019. Boehringer Ingelheim, GSK, Pfizer and Sanofi (NASDAQ:SNY) all sold brand name Zantac ...

Plaintiffs in the case have argued that ranitidine can cause cancer. The drug was marketed for years by GSK (GSK) under the brand name Zantac and by various generic drugmakers. GSK (GSK ...

The plaintiffs claim that they developed cancer due to the medication Zantac, which is used to relieve acid reflux and heartburn. The complaint names Boehringer Ingelheim Pharmaceuticals Inc ...

which originally developed the drug, and Pfizer. Kimbrow, 73, said he took Zantac from 1995 to 2019. Boehringer Ingelheim, GSK, Pfizer and Sanofi all sold brand name Zantac at various times since ...

AIG has appointed Keith Walsh as Executive Vice President and Chief Financial Officer, effective October 21. Walsh brings ...

Nevertheless, Haleon is a great stock for the current environment we’re in. The resilience of its brands is fueling investors’ interest in HLN — as are fears about a slowing U.S. economy and ...

On Wednesday, a jury in Cook County Circuit Court in Illinois ended in a mistrial in a case against Zantac manufacturer ...

British drugmaker GSK said on Wednesday it had agreed to settle two lawsuits in California that claimed its discontinued ...

Zantac -- also known as ranitidine -- was a popular heartburn drug until 2020, when the Food and Drug Administration ordered it removed from pharmacy shelves because of a potential cancer risk. While ...